Literature DB >> 2259380

Cancer. A deadly inheritance.

B Vogelstein.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2259380     DOI： 10.1038/348681a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  79 in total

Review 1.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

Review 2.  Apoptosis induced by anticancer drugs.

Authors:  J A Hickman
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

3.  Infrequency of p53 gene mutations in ependymomas.

Authors:  K L Fink; E J Rushing; S C Schold; P D Nisen
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

4.  Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.

Authors:  D Ronen; Y Teitz; N Goldfinger; V Rotter
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

5.  Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma.

Authors:  S Seregard
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

6.  Activation of cAMP signaling interferes with stress-induced p53 accumulation in ALL-derived cells by promoting the interaction between p53 and HDM2.

Authors:  Elin Hallan Naderi; Aart G Jochemsen; Heidi Kiil Blomhoff; Soheil Naderi
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

7.  RGS-GAIP-interacting protein controls breast cancer progression.

Authors:  Ling Wang; Julie S Lau; Chitta Ranjan Patra; Ying Cao; Santanu Bhattacharya; Shamit Dutta; Debashis Nandy; Enfeng Wang; Chamila N Rupasinghe; Pawan Vohra; Mark R Spaller; Debabrata Mukhopadhyay
Journal:  Mol Cancer Res       Date:  2010-10-27       Impact factor: 5.852

8.  Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.

Authors:  P A van Dam; I B Vergote; D G Lowe; J V Watson; P van Damme; J C van der Auwera; J H Shepherd
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

9.  The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.

Authors:  X Liu; C W Miller; P H Koeffler; A J Berk
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  Overexpression of p53 protein in Barrett's syndrome with malignant transformation.

Authors:  J F Fléjou; F Potet; F Muzeau; F Le Pelletier; F Fékété; D Hénin
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.